Existing studies have underscored the pivotal role of N-acetyltransferase 10(NAT10) in various cancers. However, the outcomes of protein-protein interactions between NAT10 and its protein partners in head and neck squ...Existing studies have underscored the pivotal role of N-acetyltransferase 10(NAT10) in various cancers. However, the outcomes of protein-protein interactions between NAT10 and its protein partners in head and neck squamous cell carcinoma(HNSCC) remain unexplored. In this study, we identified a significant upregulation of RNA-binding protein with serine-rich domain 1(RNPS1) in HNSCC, where RNPS1 inhibits the ubiquitination degradation of NAT10 by E3 ubiquitin ligase, zinc finger SWIM domain-containing protein 6(ZSWIM6), through direct protein interaction, thereby promoting high NAT10 expression in HNSCC. This upregulated NAT10 stability mediates the enhancement of specific tRNA ac^(4)C modifications, subsequently boosting the translation process of genes involved in pathways such as IL-6 signaling, IL-8 signaling, and PTEN signaling that play roles in regulating HNSCC malignant progression, ultimately influencing the survival and prognosis of HNSCC patients. Additionally, we pioneered the development of TRMC-seq, leading to the discovery of novel t RNA-ac^(4)C modification sites, thereby providing a potent sequencing tool for tRNAac^(4)C research. Our findings expand the repertoire of tRNA ac^(4)C modifications and identify a role of tRNA ac^(4)C in the regulation of mRNA translation in HNSCC.展开更多
Peripheral nerve injuries remain a challenging problem in need of better treatment strategies.Despite best efforts at surgical reconstruction and postoperative rehabilitation,patients are often left with persistent,de...Peripheral nerve injuries remain a challenging problem in need of better treatment strategies.Despite best efforts at surgical reconstruction and postoperative rehabilitation,patients are often left with persistent,debilitating motor and sensory deficits.There are currently no therapeutic strategies proven to enhance the regenerative process in humans.A clinical need exists for the development of technologies to promote nerve regeneration and improve functional outcomes.Recent advances in the fields of tissue engineering and nanotechnology have enabled biomaterial scaffolds to modulate the host response to tissue repair through tailored mechanical,chemical,and conductive cues.New bioengineered approaches have enabled targeted,sustained delivery of protein therapeutics with the capacity to unlock the clinical potential of a myriad of neurotrophic growth factors that have demonstrated promise in enhancing regenerative outcomes.As such,further exploration of combinatory strategies leveraging these technological advances may offer a pathway towards clinically translatable solutions to advance the care of patients with peripheral nerve injuries.This review first presents the various emerging bioengineering strategies that can be applied for the management of nerve gap injuries.We cover the rationale and limitations for their use as an alternative to autografts,focusing on the approaches to increase the number of regenerating axons crossing the repair site,and facilitating their growth towards the distal stump.We also discuss the emerging growth factor-based therapeutic strategies designed to improve functional outcomes in a multimodal fashion,by accelerating axonal growth,improving the distal regenerative environment,and preventing end-organs atrophy.展开更多
程序性死亡蛋白1(programmed cell death 1,PD-1)及其配体PD-L1(programmed death 1 ligand 1)是重要的免疫检查点,二者相互作用可负性调节效应T细胞活化与增殖,也是肿瘤细胞逃避免疫监视的重要途径。阻断PD-1与PD-L1的结合,可以解除肿...程序性死亡蛋白1(programmed cell death 1,PD-1)及其配体PD-L1(programmed death 1 ligand 1)是重要的免疫检查点,二者相互作用可负性调节效应T细胞活化与增殖,也是肿瘤细胞逃避免疫监视的重要途径。阻断PD-1与PD-L1的结合,可以解除肿瘤细胞或抗原提呈细胞对T细胞的抑制,恢复其对肿瘤细胞的识别和杀伤能力。然而,PD-L1的表达受到复杂的调控且在不同的肿瘤中呈现出差异,其主要发生在遗传、转录和转录后水平。本综述介绍PD-L1表达的调控过程及其在肿瘤免疫治疗中的作用,结合这些调控机制实现对不同特征肿瘤进行精准免疫治疗是下一步研究的重点,在肿瘤治疗中具有重要意义。展开更多
既往研究发现,SMAD特异性E3泛素蛋白连接酶1(SMAD specific E3 ubiquitin protein ligase 1,SMURF1)通过其E3泛素连接酶活性介导自噬进程,然而SMURF1的泛素化底物蛋白质仍有待进一步挖掘。本文利用免疫共沉淀(Co-IP)联合蛋白质谱分析捕...既往研究发现,SMAD特异性E3泛素蛋白连接酶1(SMAD specific E3 ubiquitin protein ligase 1,SMURF1)通过其E3泛素连接酶活性介导自噬进程,然而SMURF1的泛素化底物蛋白质仍有待进一步挖掘。本文利用免疫共沉淀(Co-IP)联合蛋白质谱分析捕获并鉴定THP-1细胞中SMURF1的相互作用蛋白质集合物,发现在THP-1细胞中SMURF1可与222种蛋白质物理性结合,RNA腺苷脱氨酶1(adenosine deaminase acting on RNA 1,ADAR1)具有较高的肽段结合分数。构建SMURF1过表达载体并转染到HEK-293T细胞中,Co-IP和Western印迹检测验证外源性SMURF1与内源性ADAR1存在相互作用。qRT-PCR和Western印迹检测结果显示,在HEK-293T细胞中过表达SMURF1后ADAR 1 mRNA水平差异无统计学意义、蛋白质水平明显降低(P<0.05)。用放线菌酮(CHX)分别处理正常和过表达SMURF1的HEK-293T细胞,Western印迹检测显示,过表达SMURF1后ADAR1的半衰期缩短(P<0.05)。进一步在HEK-293T细胞中共转染泛素(Ub)过表达载体和SMURF1过表达载体,通过Co-IP和Western印迹检测结果证实,过表达SMURF1后ADAR1的多聚泛素化水平显著增加(P<0.05)。在蛋白酶体抑制剂(MG132)作用后,Western印迹检测结果表明,蛋白酶体降解途径受抑制后SMURF1对ADAR1的负调控作用减弱(P<0.05)。本研究表明,SMURF1可以与ADAR1相互作用,催化ADAR1的多聚泛素化修饰并介导其蛋白酶体途径降解,为探索SMURF1通过影响ADAR1蛋白质稳定性而具备的多种生物学功能提供理论基础。展开更多
Although intensive interventions with low carbohydrate diets compared with higher carbohydrate diets can reduce HbA1c in people with type 2 diabetes, it is not clear if simple advice to make modest reductions in carbo...Although intensive interventions with low carbohydrate diets compared with higher carbohydrate diets can reduce HbA1c in people with type 2 diabetes, it is not clear if simple advice to make modest reductions in carbohydrate is effective in clinical practice. Forty-three people with type 2 diabetes and poor control (HbA1c > 7.5%) were randomized to receive 2 short education sessions over 6 months with a non-dietitian researcher on how to reduce carbohydrate intake by about 25% or to 2 control sessions in which the Australian Guide to Healthy Eating was provided. Hba1c and fasting glucose and lipids were measured at baseline and 3 months and 6 months. 33 volunteers attended a baseline visit;27 completed 3 months and 24 6 months. HbA1c was reduced by 0.6% - 0.7% in the low carbohydrate diet group compared with the control group (P = 0.1). Fasting glucose was reduced by 2.3 mmol/L compared with the control group at 3 months (P < 0.03) only. Changes in HbA1c at 6 months were related to baseline HbA1c in the intervention group only. Although we have obtained suggestive evidence that a low carbohydrate diet can be successfully implemented in normal practice without professional help, our results are limited by low participant numbers and further studies are required.展开更多
目的·探究衔接子相关蛋白激酶1(adaptor-associated protein kinase 1,AAK1)新的相互作用蛋白,以及除网格蛋白介导的内吞作用外AAK1介导的生物学功能。方法·通过在HEK-293T细胞中分别外源性转染带有标签的AAK1载体与空白对照...目的·探究衔接子相关蛋白激酶1(adaptor-associated protein kinase 1,AAK1)新的相互作用蛋白,以及除网格蛋白介导的内吞作用外AAK1介导的生物学功能。方法·通过在HEK-293T细胞中分别外源性转染带有标签的AAK1载体与空白对照载体,利用标签特异性的琼脂糖凝胶进行免疫共沉淀(co-immunoprecipitation,CoIP),并联合质谱分析的方法获得潜在与AAK1相互作用的蛋白;通过CoIP初步验证质谱结果;通过荧光共聚焦成像观察AAK1与其潜在结合蛋白在细胞内的空间定位;通过体外纯化重组蛋白,利用谷胱甘肽巯基转移酶融合蛋白沉降实验(glutathione-S-transferase pulldown,GST Pulldown)进一步明确蛋白间是否为直接的相互作用;通过嘌呤霉素结合实验观察AAK1对于细胞内整体翻译水平的调控作用。结果·质谱结果提示AAK1可能与以脆性X相关蛋白1(fragile X mental retardation syndrome-related protein 1,FXR1)、FXR2、脆性X智力低下蛋白(fragile X mental retardation protein 1,FMRP)三者为核心的一系列蛋白形成复合体。外源性转染AAK1-3xFLAG及FMRP-MYC质粒,利用抗FLAG琼脂糖凝胶富集AAK1-3xFLAG后,可以检测到FMRPMYC的表达;利用内源性抗体进行CoIP,发现富集AAK1可以检测到FMRP的表达。荧光共聚焦成像显示EGFP-AAK1与mCherry-FMRP在细胞质中存在部分空间共定位。GST Pulldown显示FMRP可以直接沉淀HIS6-AAK1重组蛋白。嘌呤霉素结合实验显示相同时间内嘌呤霉素标记的细胞内新合成肽段数量与AAK1蛋白表达量呈正相关。结论·AAK1与FMRP在细胞质内存在直接的相互作用,且AAK1可以提高细胞内的翻译水平。展开更多
A sparsifying transform for use in Compressed Sensing (CS) is a vital piece of image reconstruction for Magnetic Resonance Imaging (MRI). Previously, Translation Invariant Wavelet Transforms (TIWT) have been shown to ...A sparsifying transform for use in Compressed Sensing (CS) is a vital piece of image reconstruction for Magnetic Resonance Imaging (MRI). Previously, Translation Invariant Wavelet Transforms (TIWT) have been shown to perform exceedingly well in CS by reducing repetitive line pattern image artifacts that may be observed when using orthogonal wavelets. To further establish its validity as a good sparsifying transform, the TIWT is comprehensively investigated and compared with Total Variation (TV), using six under-sampling patterns through simulation. Both trajectory and random mask based under-sampling of MRI data are reconstructed to demonstrate a comprehensive coverage of tests. Notably, the TIWT in CS reconstruction performs well for all varieties of under-sampling patterns tested, even for cases where TV does not improve the mean squared error. This improved Image Quality (IQ) gives confidence in applying this transform to more CS applications which will contribute to an even greater speed-up of a CS MRI scan. High vs low resolution time of flight MRI CS re-constructions are also analyzed showing how partial Fourier acquisitions must be carefully addressed in CS to prevent loss of IQ. In the spirit of reproducible research, novel software is introduced here as FastTestCS. It is a helpful tool to quickly develop and perform tests with many CS customizations. Easy integration and testing for the TIWT and TV minimization are exemplified. Simulations of 3D MRI datasets are shown to be efficiently distributed as a scalable solution for large studies. Comparisons in reconstruction computation time are made between the Wavelab toolbox and Gnu Scientific Library in FastTestCS that show a significant time savings factor of 60×. The addition of FastTestCS is proven to be a fast, flexible, portable and reproducible simulation aid for CS research.展开更多
Objective Cisplatin(CDDP)-based chemotherapy is a first-line,drug regimen for muscle-invasive bladder cancer(BC)and metastatic bladder cancer.Clinically,resistance to CDDP restricts the clinical benefit of some bladde...Objective Cisplatin(CDDP)-based chemotherapy is a first-line,drug regimen for muscle-invasive bladder cancer(BC)and metastatic bladder cancer.Clinically,resistance to CDDP restricts the clinical benefit of some bladder cancer patients.AT-rich interaction domain 1A(ARID1A)gene mutation occurs frequently in bladder cancer;however,the role of CDDP sensitivity in BC has not been studied.Methods We established ARID1A knockout BC cell lines using CRISPR/Cas9 technology.IC50 determination,flow cytometry analysis of apoptosis,and tumor xenograft assays were performed to verify changes in the CDDP sensitivity of BC cells losing ARID1A.qRT-PCR,Western blotting,RNA interference,bioinformatic analysis,and ChIP-qPCR analysis were performed to further explore the potential mechanism of ARID1A inactivation in CDDP sensitivity in BC.Results It was found that ARID1A inactivation was associated with CDDP resistance in BC cells.Mechanically,loss of ARID1A promoted the expression of eukaryotic translation initiation factor 4A3(EIF4A3)through epigenetic regulation.Increased expression of EIF4A3 promoted the expression of hsa_circ_0008399(circ0008399),a novel circular RNA(circRNA)identified in our previous study,which,to some extent,showed that ARID1A deletion caused CDDP resistance through the inhibitory effect of circ0008399 on the apoptosis of BC cells.Importantly,EIF4A3-IN-2 specifically inhibited the activity of EIF4A3 to reduce circ0008399 production and restored the sensitivity of ARID1A inactivated BC cells to CDDP.Conclusion Our research deepens the understanding of the mechanisms of CDDP resistance in BC and elucidates a potential strategy to improve the efficacy of CDDP in BC patients with ARID1A deletion through combination therapy targeting EIF4A3.展开更多
BACKGROUND Breast cancer(BC) remains a public health problem. Tamoxifen(TAM) resistance has caused great difficulties for treatment of BC patients. Eukaryotic translation initiation factor 4E binding protein 1(EIF4EBP...BACKGROUND Breast cancer(BC) remains a public health problem. Tamoxifen(TAM) resistance has caused great difficulties for treatment of BC patients. Eukaryotic translation initiation factor 4E binding protein 1(EIF4EBP1) plays critical roles in the tumorigenesis and progression of BC. However, the expression and mechanism of EIF4EBP1 in determining the efficacy of TAM therapy in BC patients are still unclear.AIM To investigate the expression and functions of EIF4EBP1 in determining the efficacy of TAM therapy in BC patients.METHODS High-throughput sequencing data of breast tumors were downloaded from the Gene Expression Omnibus database. Differential gene expression analysis identified EIF4EBP1 to be significantly upregulated in cancer tissues. Its prognostic value was analyzed. The biological function and related pathways of EIF4EBP1 was analyzed. Subsequently, the expression of EIF4EBP1 was determined by real-time reverse transcription polymerase chain reaction and western blotting. Cell Counting Kit-8 assays, colony formation assay and wound healing assay were used to understand the phenotypes of function of EIF4EBP1.RESULTS EIF4EBP1 was upregulated in the TAM-resistant cells, and EIF4EBP1 was related to the prognosis of BC patients. Gene Set Enrichment Analysis showed that EIF4EBP1 might be involved in Hedgehog signaling pathways. Decreasing the expression of EIF4EBP1 could reverse TAM resistance, whereas overexpression of EIF4EBP1 promoted TAM resistance.CONCLUSION This study indicated that EIF4EBP1 was overexpressed in the BC and TAM-resistant cell line, which increased cell proliferation, invasion, migration and TAM resistance in BC cells.展开更多
基金supported by the National Natural Science Foundation of China(82173362 and 81872409)the Guangdong Basic and Applied Basic Research Foundation(2019A1515110110)。
文摘Existing studies have underscored the pivotal role of N-acetyltransferase 10(NAT10) in various cancers. However, the outcomes of protein-protein interactions between NAT10 and its protein partners in head and neck squamous cell carcinoma(HNSCC) remain unexplored. In this study, we identified a significant upregulation of RNA-binding protein with serine-rich domain 1(RNPS1) in HNSCC, where RNPS1 inhibits the ubiquitination degradation of NAT10 by E3 ubiquitin ligase, zinc finger SWIM domain-containing protein 6(ZSWIM6), through direct protein interaction, thereby promoting high NAT10 expression in HNSCC. This upregulated NAT10 stability mediates the enhancement of specific tRNA ac^(4)C modifications, subsequently boosting the translation process of genes involved in pathways such as IL-6 signaling, IL-8 signaling, and PTEN signaling that play roles in regulating HNSCC malignant progression, ultimately influencing the survival and prognosis of HNSCC patients. Additionally, we pioneered the development of TRMC-seq, leading to the discovery of novel t RNA-ac^(4)C modification sites, thereby providing a potent sequencing tool for tRNAac^(4)C research. Our findings expand the repertoire of tRNA ac^(4)C modifications and identify a role of tRNA ac^(4)C in the regulation of mRNA translation in HNSCC.
基金supported by The Plastic Surgery Foundation Research Pilot Grant,No.627383(to KAS).
文摘Peripheral nerve injuries remain a challenging problem in need of better treatment strategies.Despite best efforts at surgical reconstruction and postoperative rehabilitation,patients are often left with persistent,debilitating motor and sensory deficits.There are currently no therapeutic strategies proven to enhance the regenerative process in humans.A clinical need exists for the development of technologies to promote nerve regeneration and improve functional outcomes.Recent advances in the fields of tissue engineering and nanotechnology have enabled biomaterial scaffolds to modulate the host response to tissue repair through tailored mechanical,chemical,and conductive cues.New bioengineered approaches have enabled targeted,sustained delivery of protein therapeutics with the capacity to unlock the clinical potential of a myriad of neurotrophic growth factors that have demonstrated promise in enhancing regenerative outcomes.As such,further exploration of combinatory strategies leveraging these technological advances may offer a pathway towards clinically translatable solutions to advance the care of patients with peripheral nerve injuries.This review first presents the various emerging bioengineering strategies that can be applied for the management of nerve gap injuries.We cover the rationale and limitations for their use as an alternative to autografts,focusing on the approaches to increase the number of regenerating axons crossing the repair site,and facilitating their growth towards the distal stump.We also discuss the emerging growth factor-based therapeutic strategies designed to improve functional outcomes in a multimodal fashion,by accelerating axonal growth,improving the distal regenerative environment,and preventing end-organs atrophy.
文摘程序性死亡蛋白1(programmed cell death 1,PD-1)及其配体PD-L1(programmed death 1 ligand 1)是重要的免疫检查点,二者相互作用可负性调节效应T细胞活化与增殖,也是肿瘤细胞逃避免疫监视的重要途径。阻断PD-1与PD-L1的结合,可以解除肿瘤细胞或抗原提呈细胞对T细胞的抑制,恢复其对肿瘤细胞的识别和杀伤能力。然而,PD-L1的表达受到复杂的调控且在不同的肿瘤中呈现出差异,其主要发生在遗传、转录和转录后水平。本综述介绍PD-L1表达的调控过程及其在肿瘤免疫治疗中的作用,结合这些调控机制实现对不同特征肿瘤进行精准免疫治疗是下一步研究的重点,在肿瘤治疗中具有重要意义。
文摘既往研究发现,SMAD特异性E3泛素蛋白连接酶1(SMAD specific E3 ubiquitin protein ligase 1,SMURF1)通过其E3泛素连接酶活性介导自噬进程,然而SMURF1的泛素化底物蛋白质仍有待进一步挖掘。本文利用免疫共沉淀(Co-IP)联合蛋白质谱分析捕获并鉴定THP-1细胞中SMURF1的相互作用蛋白质集合物,发现在THP-1细胞中SMURF1可与222种蛋白质物理性结合,RNA腺苷脱氨酶1(adenosine deaminase acting on RNA 1,ADAR1)具有较高的肽段结合分数。构建SMURF1过表达载体并转染到HEK-293T细胞中,Co-IP和Western印迹检测验证外源性SMURF1与内源性ADAR1存在相互作用。qRT-PCR和Western印迹检测结果显示,在HEK-293T细胞中过表达SMURF1后ADAR 1 mRNA水平差异无统计学意义、蛋白质水平明显降低(P<0.05)。用放线菌酮(CHX)分别处理正常和过表达SMURF1的HEK-293T细胞,Western印迹检测显示,过表达SMURF1后ADAR1的半衰期缩短(P<0.05)。进一步在HEK-293T细胞中共转染泛素(Ub)过表达载体和SMURF1过表达载体,通过Co-IP和Western印迹检测结果证实,过表达SMURF1后ADAR1的多聚泛素化水平显著增加(P<0.05)。在蛋白酶体抑制剂(MG132)作用后,Western印迹检测结果表明,蛋白酶体降解途径受抑制后SMURF1对ADAR1的负调控作用减弱(P<0.05)。本研究表明,SMURF1可以与ADAR1相互作用,催化ADAR1的多聚泛素化修饰并介导其蛋白酶体途径降解,为探索SMURF1通过影响ADAR1蛋白质稳定性而具备的多种生物学功能提供理论基础。
文摘Although intensive interventions with low carbohydrate diets compared with higher carbohydrate diets can reduce HbA1c in people with type 2 diabetes, it is not clear if simple advice to make modest reductions in carbohydrate is effective in clinical practice. Forty-three people with type 2 diabetes and poor control (HbA1c > 7.5%) were randomized to receive 2 short education sessions over 6 months with a non-dietitian researcher on how to reduce carbohydrate intake by about 25% or to 2 control sessions in which the Australian Guide to Healthy Eating was provided. Hba1c and fasting glucose and lipids were measured at baseline and 3 months and 6 months. 33 volunteers attended a baseline visit;27 completed 3 months and 24 6 months. HbA1c was reduced by 0.6% - 0.7% in the low carbohydrate diet group compared with the control group (P = 0.1). Fasting glucose was reduced by 2.3 mmol/L compared with the control group at 3 months (P < 0.03) only. Changes in HbA1c at 6 months were related to baseline HbA1c in the intervention group only. Although we have obtained suggestive evidence that a low carbohydrate diet can be successfully implemented in normal practice without professional help, our results are limited by low participant numbers and further studies are required.
文摘目的·探究衔接子相关蛋白激酶1(adaptor-associated protein kinase 1,AAK1)新的相互作用蛋白,以及除网格蛋白介导的内吞作用外AAK1介导的生物学功能。方法·通过在HEK-293T细胞中分别外源性转染带有标签的AAK1载体与空白对照载体,利用标签特异性的琼脂糖凝胶进行免疫共沉淀(co-immunoprecipitation,CoIP),并联合质谱分析的方法获得潜在与AAK1相互作用的蛋白;通过CoIP初步验证质谱结果;通过荧光共聚焦成像观察AAK1与其潜在结合蛋白在细胞内的空间定位;通过体外纯化重组蛋白,利用谷胱甘肽巯基转移酶融合蛋白沉降实验(glutathione-S-transferase pulldown,GST Pulldown)进一步明确蛋白间是否为直接的相互作用;通过嘌呤霉素结合实验观察AAK1对于细胞内整体翻译水平的调控作用。结果·质谱结果提示AAK1可能与以脆性X相关蛋白1(fragile X mental retardation syndrome-related protein 1,FXR1)、FXR2、脆性X智力低下蛋白(fragile X mental retardation protein 1,FMRP)三者为核心的一系列蛋白形成复合体。外源性转染AAK1-3xFLAG及FMRP-MYC质粒,利用抗FLAG琼脂糖凝胶富集AAK1-3xFLAG后,可以检测到FMRPMYC的表达;利用内源性抗体进行CoIP,发现富集AAK1可以检测到FMRP的表达。荧光共聚焦成像显示EGFP-AAK1与mCherry-FMRP在细胞质中存在部分空间共定位。GST Pulldown显示FMRP可以直接沉淀HIS6-AAK1重组蛋白。嘌呤霉素结合实验显示相同时间内嘌呤霉素标记的细胞内新合成肽段数量与AAK1蛋白表达量呈正相关。结论·AAK1与FMRP在细胞质内存在直接的相互作用,且AAK1可以提高细胞内的翻译水平。
文摘A sparsifying transform for use in Compressed Sensing (CS) is a vital piece of image reconstruction for Magnetic Resonance Imaging (MRI). Previously, Translation Invariant Wavelet Transforms (TIWT) have been shown to perform exceedingly well in CS by reducing repetitive line pattern image artifacts that may be observed when using orthogonal wavelets. To further establish its validity as a good sparsifying transform, the TIWT is comprehensively investigated and compared with Total Variation (TV), using six under-sampling patterns through simulation. Both trajectory and random mask based under-sampling of MRI data are reconstructed to demonstrate a comprehensive coverage of tests. Notably, the TIWT in CS reconstruction performs well for all varieties of under-sampling patterns tested, even for cases where TV does not improve the mean squared error. This improved Image Quality (IQ) gives confidence in applying this transform to more CS applications which will contribute to an even greater speed-up of a CS MRI scan. High vs low resolution time of flight MRI CS re-constructions are also analyzed showing how partial Fourier acquisitions must be carefully addressed in CS to prevent loss of IQ. In the spirit of reproducible research, novel software is introduced here as FastTestCS. It is a helpful tool to quickly develop and perform tests with many CS customizations. Easy integration and testing for the TIWT and TV minimization are exemplified. Simulations of 3D MRI datasets are shown to be efficiently distributed as a scalable solution for large studies. Comparisons in reconstruction computation time are made between the Wavelab toolbox and Gnu Scientific Library in FastTestCS that show a significant time savings factor of 60×. The addition of FastTestCS is proven to be a fast, flexible, portable and reproducible simulation aid for CS research.
基金This work was supported by grants from the National Natural Science Foundation of China(No.81974396,No.81874091,No.82072840,and No.82102734)the Natural Science Foundation of Hubei Province(No.2020CFB829)the Health Commission of Hubei Province Scientific Research Project(No.WJ2021F081).
文摘Objective Cisplatin(CDDP)-based chemotherapy is a first-line,drug regimen for muscle-invasive bladder cancer(BC)and metastatic bladder cancer.Clinically,resistance to CDDP restricts the clinical benefit of some bladder cancer patients.AT-rich interaction domain 1A(ARID1A)gene mutation occurs frequently in bladder cancer;however,the role of CDDP sensitivity in BC has not been studied.Methods We established ARID1A knockout BC cell lines using CRISPR/Cas9 technology.IC50 determination,flow cytometry analysis of apoptosis,and tumor xenograft assays were performed to verify changes in the CDDP sensitivity of BC cells losing ARID1A.qRT-PCR,Western blotting,RNA interference,bioinformatic analysis,and ChIP-qPCR analysis were performed to further explore the potential mechanism of ARID1A inactivation in CDDP sensitivity in BC.Results It was found that ARID1A inactivation was associated with CDDP resistance in BC cells.Mechanically,loss of ARID1A promoted the expression of eukaryotic translation initiation factor 4A3(EIF4A3)through epigenetic regulation.Increased expression of EIF4A3 promoted the expression of hsa_circ_0008399(circ0008399),a novel circular RNA(circRNA)identified in our previous study,which,to some extent,showed that ARID1A deletion caused CDDP resistance through the inhibitory effect of circ0008399 on the apoptosis of BC cells.Importantly,EIF4A3-IN-2 specifically inhibited the activity of EIF4A3 to reduce circ0008399 production and restored the sensitivity of ARID1A inactivated BC cells to CDDP.Conclusion Our research deepens the understanding of the mechanisms of CDDP resistance in BC and elucidates a potential strategy to improve the efficacy of CDDP in BC patients with ARID1A deletion through combination therapy targeting EIF4A3.
文摘BACKGROUND Breast cancer(BC) remains a public health problem. Tamoxifen(TAM) resistance has caused great difficulties for treatment of BC patients. Eukaryotic translation initiation factor 4E binding protein 1(EIF4EBP1) plays critical roles in the tumorigenesis and progression of BC. However, the expression and mechanism of EIF4EBP1 in determining the efficacy of TAM therapy in BC patients are still unclear.AIM To investigate the expression and functions of EIF4EBP1 in determining the efficacy of TAM therapy in BC patients.METHODS High-throughput sequencing data of breast tumors were downloaded from the Gene Expression Omnibus database. Differential gene expression analysis identified EIF4EBP1 to be significantly upregulated in cancer tissues. Its prognostic value was analyzed. The biological function and related pathways of EIF4EBP1 was analyzed. Subsequently, the expression of EIF4EBP1 was determined by real-time reverse transcription polymerase chain reaction and western blotting. Cell Counting Kit-8 assays, colony formation assay and wound healing assay were used to understand the phenotypes of function of EIF4EBP1.RESULTS EIF4EBP1 was upregulated in the TAM-resistant cells, and EIF4EBP1 was related to the prognosis of BC patients. Gene Set Enrichment Analysis showed that EIF4EBP1 might be involved in Hedgehog signaling pathways. Decreasing the expression of EIF4EBP1 could reverse TAM resistance, whereas overexpression of EIF4EBP1 promoted TAM resistance.CONCLUSION This study indicated that EIF4EBP1 was overexpressed in the BC and TAM-resistant cell line, which increased cell proliferation, invasion, migration and TAM resistance in BC cells.